tenofovir has been researched along with Mitochondrial Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, P; Isaac, B; Ramamoorthy, H | 1 |
| Kirschner, J; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA; Wiech, T | 1 |
2 other study(ies) available for tenofovir and Mitochondrial Diseases
| Article | Year |
|---|---|
Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney.
Topics: Adenine; Animals; Antioxidants; Glutathione; Glutathione Peroxidase; Kidney; Kidney Tubules, Proximal; Mitochondria; Mitochondrial Diseases; Organophosphonates; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Tenofovir | 2013 |
Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
Topics: Adenine; Animals; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Electron Transport; Electron Transport Complex IV; Kidney Tubules, Proximal; Male; Microscopy, Electron, Transmission; Mitochondria; Mitochondrial Diseases; NADH Dehydrogenase; Organophosphonates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |